TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent
- Conditions
- Interventions
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2008-10-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1326
- Registration Number
- NCT00292474
- Locations
- 🇺🇸
Stephen G.Ellis, Cleveland, Ohio, United States
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
- Conditions
- Interventions
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2010-08-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 488
- Registration Number
- NCT00287573
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Maine Medical Center, Portland, Maine, United States
🇺🇸South Carolina Heart Center, Columbia, South Carolina, United States
Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing
- Conditions
- First Posted Date
- 2006-02-06
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 903
- Registration Number
- NCT00286858
- Locations
- 🇬🇵
CHU de Point à pitre, Pointe-a-Pitre, Guadeloupe
🇫🇷Polyclinique Sévigné, Cesson Sevigne, France
🇫🇷CH DAX, DAX, France
Treatment for Migraines With an Implantable Device
- First Posted Date
- 2006-02-03
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 179
- Registration Number
- NCT00286078
- Locations
- 🇺🇸
New England Regional Headache Center, Worcester, Massachusetts, United States
🇺🇸Thomas Jefferson University - Jefferson Headache, Philadelphia, Pennsylvania, United States
🇺🇸Walton Rehabilitation Hospital, Augusta, Georgia, United States
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts
- Conditions
- Interventions
- First Posted Date
- 2006-01-30
- Last Posted Date
- 2009-11-01
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 514
- Registration Number
- NCT00283413
- Locations
- 🇺🇸
Providence Hospital, Columbia, South Carolina, United States
🇺🇸Charleston Area Medical Center, Charleston, West Virginia, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction
- Conditions
- Interventions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2014-10-09
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 501
- Registration Number
- NCT00275990
- Locations
- 🇮🇹
Careggi Hospital, Division of Cardiology, Florence, Italy
MODULA Modul 5 BEAT-HF
- Conditions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00273091
- Locations
- 🇩🇪
Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9, Bad Berka, Germany
Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
- Conditions
- Interventions
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 212
- Registration Number
- NCT00261378
- Locations
- 🇨🇭
Inselspital Bern, Bern, Switzerland
🇨🇭Hopitaux Universitaires de Geneve, Geneve, Switzerland
🇦🇹Medizinische Universitat Innsbruck, Innsbruck, Austria
The Boston Scientific ENOVUS Trial
- Conditions
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT00246038
The HF-HRV Registry
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2006-11-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1400
- Registration Number
- NCT00236236